BIOCRYST PHARMACEUTICALS INC's ticker is BCRX and the CUSIP is 09058V103. A total of 234 filers reported holding BIOCRYST PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.15 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2023 | $485,190 | -15.4% | 81,000 | 0.0% | 0.15% | -13.9% |
| Q3 2023 | $573,480 | +0.6% | 81,000 | 0.0% | 0.17% | -0.6% |
| Q2 2023 | $570,240 | -15.6% | 81,000 | 0.0% | 0.17% | -17.9% |
| Q1 2023 | $675,540 | -27.4% | 81,000 | 0.0% | 0.21% | -30.5% |
| Q4 2022 | $929,880 | -8.9% | 81,000 | 0.0% | 0.30% | -19.1% |
| Q3 2022 | $1,021,000 | +19.1% | 81,000 | 0.0% | 0.38% | +24.0% |
| Q2 2022 | $857,000 | -34.9% | 81,000 | 0.0% | 0.30% | -26.9% |
| Q1 2022 | $1,317,000 | -13.4% | 81,000 | -19.0% | 0.42% | -12.4% |
| Q4 2021 | $1,521,000 | +5.8% | 100,000 | 0.0% | 0.48% | -1.7% |
| Q3 2021 | $1,437,000 | – | 100,000 | – | 0.48% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| VHCP Management, LLC | 1,744,356 | $18,455,000 | 9.59% |
| RA Capital Management | 4,347,456 | $45,996,000 | 3.30% |
| Cormorant Asset Management, LP | 1,168,000 | $12,357,000 | 2.84% |
| Baker Brothers Advisors | 5,867,031 | $62,073,000 | 0.79% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 907,920 | $9,606,000 | 0.39% |
| QVT Financial LP | 525,734 | $5,562,000 | 0.32% |
| EAM Investors, LLC | 114,548 | $1,212,000 | 0.22% |
| FRANKLIN STREET ADVISORS INC /NC | 93,000 | $984,000 | 0.20% |
| THB ASSET MANAGEMENT | 301,529 | $3,190,000 | 0.19% |
| TPG Group Holdings (SBS) Advisors, Inc. | 1,162,269 | $12,297,000 | 0.13% |